1039433-08-3

Upstream product

• 190448-59-0 (1S)-1-(4-fluorophenyl)-3-[(2S,3R)-2-(4-hydroxyphenyl)-1-(4-iodophenyl)-4-oxoazetidin-3-yl]propyl acetate 
• 1025468-02-3 C₈H₁₂O₃ 
• 932724-70-4 (1S)-3-[(2S,3R)-2-(4-{[5-(acetyloxy)-2,2-dimethyl-1,3-dioxan-5-yl]ethynyl}phenyl)-1-(4-{3-[(methylsulfonyl)amino]propyl}phenyl)-4-oxoazetidin-3-yl]-1-(4-fluorophenyl)propyl acetate 
• 917565-59-4 (1S)-1-(4-fluorophenyl)-3-[(3R,4S)-1-(4-{3-[(methylsulfonyl)amino]propyl}phenyl)-2-oxo-4-(4-{[(trifluoromethyl)-sulfonyl]oxy}phenyl)azetidin-3-yl]propyl acetate 
• 932724-68-0 2,2-dimethyl-5-ethynyl-1,3-dioxan-5-yl acetate 
• 917565-57-2 4-[(2S,3R)-3-[(3S)-3-(acetyloxy)-3-(4-fluorophenyl)propyl]-1-(4-{3-[(methylsulfonyl)amino]prop-1-yn-1-yl}phenyl)-4-oxoazetidin-2-yl]phenyl acetate 
• 917565-48-1 4-[(2S,3R)-3-[(3S)-3-(acetyloxy)-3-(4-fluorophenyl)propyl]-1-(4-iodophenyl)-4-oxoazetidin-2-yl]phenyl acetate 
• 932724-71-5 (1S)-3-[(2S,3R)-2-(4-{2-[5-(acetyloxy)-2.2-dimethyl-1,3-dioxan-5-yl]ethyl}phenyl)-1-(4-{3-[(methylsulfonyl)amino]propyl}phenyl)-4-oxoazetidin-3-yl]-1-(4-fluorophenyl)propyl acetate 

Downstream Products

• 1039433-46-9 methyl (2S,3S,4S,5R,6R)-3,4,5-tris(acetyloxy)-6-[2-(acetyloxy)-4-{4-[(2S,3R)-3-[(3S)-3-(acetyloxy)-3-(4-fluorophenyl)propyl]-1-(4-{3-[(methylsulfonyl)amino]propyl}phenyl)-4-oxoazetidin-2-yl]phenyl}-2-(hydroxymethyl)butoxy]tetrahydro-2H-pyran-2-carboxylate 

Relevant academic research and scientific papers

ANTI-HYPERCHOLESTEROLEMIC COMPOUND

This invention provides a novel crystalline form of N-[3-(4-{(2S,3R)-2-{4-[3,4-dihydroxy-3-(hydroxymethyl)butyl]phenyl}-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxoazetidin-1-yl}phen yl)propyl]methanesulfonamide. The compound is useful for lowering p